Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival

In Vivo

Volumn 28, Issue 3, 2014, Pages 315-326

  Bouchagier, Konstantinos A ^a   Assimakopoulos, Stelios F ^a   Karavias, Dimitrios D ^a   Maroulis, Ioannis ^a   Tzelepi, Vassiliki ^a   Kalofonos, Haralabos ^a   Karavias, Dionissios D ^a   Kardamakis, Dimitrios ^a   Scopa, Chrisoula D ^a   Tsamandas, Athanassios C ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Claudins; Hepatocellular carcinoma; Occludin; Tight junction proteins

Indexed keywords

CLAUDIN 1; CLAUDIN 4; CLAUDIN 5; CLAUDIN 7; OCCLUDIN; CLAUDIN; CLDN7 PROTEIN, HUMAN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; LIVER CELL CARCINOMA; LIVER NODULE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR DIFFERENTIATION; VERY ELDERLY; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; TUMOR RECURRENCE; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CLAUDIN-1; CLAUDIN-4; CLAUDIN-5; CLAUDINS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OCCLUDIN; PROGNOSIS; TUMOR BURDEN;

EID: 84918529877     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. González-Mariscal L, Tapia R and Chamorro D: Review crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778: 729-756, 2008.
2. Assimakopoulos SF, Papageorgiou I and Charonis A: Enterocytes' tight junctions: From molecules to diseases. World J Gastrointest Pathophysiol 15: 123-137, 2011.
3. Cheung ST, Lee YT, Ho JCY, Lo KK and Fan ST: Claudin -10 enhanced metastatic potential in Hepatocellular Ca with MMP activation and modified expression profile of other claudin family members. European J Cancer Supplements 5: 85-86, 2007.
4. Higashi Y, Suzuki S, Sakaguchi T, Nakamura T, Baba S, Reinecker HC, Nakamura S and Konno H: Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma. J Surg Res 13: 68-76, 2007.
5. Sakaguchi T, Suzuki S, Higashi H, Inaba K, Nakamura S, Baba S, Kato T and Konno H: Expression of tight junction protein claudin-5 in tumor vessels and sinusoidal endothelium in patients with hepatocellular carcinoma. J Surg Res 147: 123-131, 2008
6. Edmondson HA and Steiner PE: Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer 7: 462-503, 1954.
7. Liver. In: AJCC Cancer Staging Handbook, From the Atlas Staging Seventh Manual Edition, Edge SB, ed. Springer, NY, pp. 237-245, 2010.
8. Lechpammer M, Resnick MB, Sabo E, Yakirevich E, Greaves WO, Sciandra KT, Tavares R, Noble LC, DeLellis RA and Wang LJ: The diagnostic and prognostic utility of claudin expression in renal cell neoplasms. Mod Pathol 21: 1320-1329, 2008.
9. Nakanishi K, Ogata S, Hiroi S, Tominaga S, Aida S and Kawai T: Expression of occludin and claudins 1, 3, 4, and 7 in urothelial carcinoma of the upper urinary tract. Am J Clin Pathol 130: 43-49, 2008.
10. Huang Y, Li LZ, Zhang CZ, Yi C, Liu LL, Zhou X, Xie GB, Cai MY, Li Y and Yun JP: Decreased expression of zinc-alpha2- glycoprotein in hepatocellular carcinoma associates with poor prognosis. J Transl Med 10: 106, 2012.
11. Koval M: Claudins-Key pieces in the tight junction puzzle. J Cell Commun Adhes 13: 127-138, 2006.
12. Angelow S, Ahistrom R and S.L.Yu A: Biology of claudins. Am J Physiol Renal Physiol 295: 867-876, 2008.
13. Cereijido M, Contreras RG, Flores-Benítez D, Flores-Maldonado C, Larre I, Ruiz A and Shoshani L: Review article: New diseases derived or associated with the tight junction. Arch Med Res 38: 465-478, 2007.
14. Swisshelm K, Macek R and Kubbies M: Role of claudins in tumorigenesis. J Adv Drug Deliv Rev 57: 919-928, 2005.
15. Tzelepi VN, Tsamandas AC, Vlotinou HD, Vagianos CE and Scopa CD: Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms. Mod Pathol 21: 22-30, 2008.
16. Martin TA and Jiang WG: Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 1788: 872-891, 2009.
17. Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO, Fan ST and So S: Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res 11: 551-556, 2005.
18. Ip YC, Cheung ST, Lee YT, Ho JC and Fan ST: Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cells. Mol Cancer Ther 6: 2858-2867, 2007.
19. Huang GW, Ding X, Chen SL, and Zeng L: Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival. J Cancer Res Clin Oncol 137: 1213-1218, 2011.
20. Orbán E, Szabó E, Lotz G, Kupcsulik P, Páska A, Schaff Z and Kiss A: Different Expression of occludin and ZO-1 in primary and metastatic liver tumors. Pathol Oncol Res 14: 299-306, 2008.
21. Orbán E, Schaff Z, Kiss A, Kupcsulik P, Szijjarto A and Paska C: Different expression of tight junction proteins in HCC and metastatic liver tumors. Eur J Cancer (Suppl) 3: 50, 2005.
22. Kiss A, Paska C, Orbán E, Lotz G, Szijjarto A, Kupcsulik P and Scahff Z: Up-regulated claudin-1 and down-regulated claudin -3 and claudin-4 expression differentiates human hepatocellular carcinoma from colorectal liver metastasis. Eur J Cancer (Suppl) 3: 46, 2005.
23. Holczbauer A, Lotz G, Batmunkh E, Szijjarto A, Kupcsulik P , Schaff Z and Kiss A: Human hepatocellular carcinoma is characterized by different claudin-4 expression pattern with respect to cirrhosis and HCV infection. J Hepatol 46: 165, 2007.
24. Lodi C, Szabo E, Batmunkh E, Holczbauer A, Kiss A, Illyes G, Paku S, Scaff Z and Nagy P: High expression of claudin-7 during liver regeneration. J Hepatol 44: 136-137, 2006.
25. Brokalaki EI, Weber F, Sotiropoulos GC, Daoudaki M, Cicinnati VR and Beckebaum S: Claudin-7 expression in hepatocellular carcinoma. Transplant Proc 44: 2737-2740, 2012.